Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial

Ramzy H Rimawi1, Mark A Mazer, Dawd S Siraj

  • 1Division of Infectious Diseases, Brody School of Medicine-East Carolina University, Greenville, NC, USA. RamzyRimawi@hotmail.com

Abstract

Insights

An infectious disease fellow

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Health Economics

Background:

  • Antimicrobial stewardship programs (ASPs) are crucial for reducing unnecessary antimicrobial use in hospitals.
  • Data on ASP effectiveness in high-use areas like the medical intensive care unit (MICU) is limited.
  • This study evaluated the impact of an infectious disease (ID) fellow's regular interaction with the MICU team.

Purpose of the Study:

  • To assess the impact of an ID fellow's regular engagement on guideline compliance, antimicrobial expenditure, and healthcare costs within a medical ICU.
  • To evaluate changes in antimicrobial use patterns and patient outcomes following the intervention.

Main Methods:

  • A prospective intervention study comparing a 3-month retrospective period with a subsequent 3-month intervention period.
  • Reviewed 246 patient charts in a 24-bed medical ICU to assess guideline compliance, demographics, and microbiology.
  • An ID fellow actively reviewed charts and discussed antimicrobial therapy with the MICU team during the intervention.

Main Results:

  • Significant reductions were observed in the use of extended-spectrum penicillins, carbapenems, vancomycin, and metronidazole (p<0.05).
  • The intervention group showed improved adherence to treatment guidelines (p<0.0001), reduced mechanical ventilation days (p=0.0053), and shorter length of stay (p=0.0188).
  • Annual healthcare savings of $89,944 were estimated from early antibiotic cessation alone, with a significant reduction in hospital mortality (p=0.0367).

Conclusions:

  • Regular interaction with an infectious disease practitioner significantly reduces antimicrobial overuse in the MICU.
  • Earlier modification or cessation of antibiotics, facilitated by ID consultation, did not increase mortality.
  • This approach lowers healthcare costs, enhances education, and improves interdisciplinary collaboration.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...